PHP115 Geographical Distribution of Pharmacies Versus Population: The Case of Two Capital Cities in Iran  by Kheirandish, M. et al.
frequencies were available. Shares of testers by therapies (OAD/INSULIN) were
10.0% and 21.8%. Physicians recommended an average of 5.9 tests per week, pa-
tients performed 2.8 (47.5%). For OAD/INSULIN test-frequencies were 2.8 and 2.2.
Doctors rated the SMBG adherence as good or very good in 43% of cases.
CONCLUSIONS: In community centers the vast majority of patients have type 2
diabetes. FPG values were broadly documented, but the therapy quality marker
HbA1 is only available for the minority of patients. SMBG was more common with
insulin users, but clearly below guideline recommendations. It needs to be deter-
mined which measures could potentially improve the current practice in diabetes
care in order to strengthen the role of community health centers in managing the
diabetes epidemic in China.
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FAILURE FOR COST-SHARING SCHEMES TO TAKE OFF IN INDIA: WHAT CAN BE
THE ACCESS SOLUTION?
Kirpekar S
Double Helix Consulting, London, UK
OBJECTIVES:With high costs of some oncology and biological therapies, manufac-
turers have introduced patient access schemes in Asian countries including Indo-
nesia,Malaysia, Philippines andChinawhere the out-of-pocket is themain funding
and access mechanism. These schemes have been welcomed by stakeholders in-
volved including patients, clinicians and governments. Our objectivewas to under-
stand why such programmes have not succeeded in India despite a large middle
class and almost complete out-of-pocket funding for pharmaceuticals, and to find
possible ways to overcome the hurdles presented. METHODS: The approach in-
volved desk research followed by primary research across stakeholders in India.
Twelve in-depth telephone interviews were conducted with stakeholders in the
public and private sectors, NGOs, leading physicians and manufacturers. The in-
formation collected was assessed and analysed. RESULTS:Majority of the respon-
dents (n10) quoted bureaucracy and the informal economy, and thus difficulties
with means-testing as the twomost important reasons for the schemes not taking
up. General ignorance about the potential of such schemes and cynicism surround-
ing them are a deterrent. Unethical medical practice, a great patient – provider
knowledge gap and a lack of streamlined infrastructure for scheme delivery are
thought to be important factors. Respondents confirmed that majority of the large
middle class lacks access to innovative medicines for many diseases. The Gleevec
patient access scheme was quoted by a few respondents as a rare example of such
a scheme being run. Partnering with the public sector and NGOs was thought to be
an alternative way out. There was mention of many local NGOs/charities which
fund targeted oncology therapies for those with limited resources. CONCLUSIONS:
India needs tailored, innovative ways of accessing high cost drugs for its local
context being different from those in other countries in the region. Public-private
partnerships involving large stakeholders such as theMinistry of Railways could be
an option.
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OBJECTIVES: Access to medications is one of the main goals of Iran National Drug
Policy (NDP). Being a function of multifactors such as distribution of pharmacies, if
the geographical access is observed, drug accessibility is gauranteed to some ex-
tent. The aim of this study is to compare the Geographical distribution of pharma-
cies versus population in two capital cities of Iran. METHODS: Two cities of Iran
with strategical and transitional importance with cultural and socioeconomical
differences (Khorramabad and Ahwaz) were selected. In the first step the popula-
tion of different regions was collected from state government databases. Further-
more all of the pharmacies’ locations in these two cities were detected through
their Food andDrug deputies. The percent of population and pharmacies located in
each region were calculated and compared together by differentiating relatad per-
cents inorder to find an overview of present status of distribution and access to
pharmacies. RESULTS: Ahwaz and Khorramabad, twowest-southern cities of Iran,
with a population of approximately 1,000,000 and 5200,000 are seperated to eight
and three regions respectively. Unlike Khorramabad, an even distribution of pop-
ulation was found in Ahwaz. The differences in percent of population versus phar-
macies in order from first to eighth region of Ahwaz were found as followed: 13.8,
3.9, -4, -8.3, 6.1, -2.6, -5.6 and -3.3. Those of the three regions of Khorramabad were
-18, 17 and 1. CONCLUSIONS: The results show the distribution of pharmacies in
both cities does not match that of population in most regions. However in one
region of Khorramabad and three regions of Ahwaz the distribution was accept-
able. This can be justified by the fact that physicians are mostly concentrated in
few regions that attract the pharmacists. It should be noted that the suitablity of
population and pharmcies’ distribution is one of the most important factors in
evaluating access to medicine.
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OBJECTIVES: Chronic disease has become a major problem affecting the health of
the Chinese population. In response to this situation, the New Rural Cooperative
Medical Scheme (NRCMS) has begun to provide health cover for outpatients with
chronic disease expenses, made possible by the increased risk pool of recent years.
We compared the differences between benefit packages for chronic disease outpa-
tients in 32 counties, in order to assess their population reach, equity and cost
implications and to formulate recommendations for policy makers. METHODS:
Information on the various benefit packages was located by searching the official
NRCMS websites in Chinese at the end of 2009. We developed a conceptual frame-
work based on the three main criteria: 1) population coverage; 2) service coverage;
and 3) costs with various subcriteris to compare benefit packages in 32 counties
across China. Chronic diseases were classified according to the ICD-10. RESULTS:
With the intention of avoiding “moral hazard” county NRCMS offices have devel-
oped complex processes to define benefit packages for chronic diseases. These
have resulted in substantial differences in benefit package equity and cost between
counties. In most counties chronic disease patients find it very difficult to become
beneficiaries. Forty-one chronic diseaseswere identified in the 32 counties, varying
between 4 and 28 per individual county. We also found large discrepancies in
co-payment rates, deductibles, ceilings, coverage of drugs and tests, accredited
hospitals and reimbursement frequency. CONCLUSIONS: Reimbursement proce-
dures are remarkably diverse in different counties. Population coverage, service
coverage and cost of benefit packages for chronic diseases vary substantially in the
32 counties studied. This reflects the new policy of decentralization of decision
making to the county-level resulting in a “postcode lottery” of patient benefits.
National regulation to redress these inefficiencies and inequities is urgently
needed.
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OBJECTIVES: To evaluate health insurance coverage rate among poor and disad-
vantaged citizens and study the cause and condition of not being involved in health
insurance. METHODS: The sampling size was estimated by using the number of
poor and needy in selected districts. By using multistage–sampling method, con-
centration of poor and poverty group among the total person of selected districts
were calculated. There are sampling size at 5% sampling error (d5%), confidence
interval (CI95%) and the influence of non-sampling error estimated. RESULTS: In
the first years of health insurance in Mongolia, there was coverage achieved at
96-97%, but later it decreased because of diversity of employment‘s structure, in-
creasing unemployment rate, and most influential factor as PHC was excluded
from social health insurance. The result shows, HI coverage was 95.3% in 1998, but
this rate was decreased till 84.4% in 2008. 95-97% of people who were involved in
the survey, have lower income than living standard. According to the pattern of
age, majority includes 26-35 aged economic hummers and as of gender, there were
44.79 % male and 55.21% female. To survey whether all people who were involved
in the survey, got covered by health insurance last 3 years, there were 47.14% of
them involved in health insurance. As forms of paying insurance fee, 17.3% paid
insurance fee by voluntary, 49.17% paid by government and 33.7% paid by mixed
forms. To survey on the health insurance coverage during the survey, 42.4% were
involved. As forms of paying insurance fee, 27.61% paid by voluntary, 41.1% paid by
mixed. CONCLUSIONS: The health insurance cannot protect poor and disadvan-
taged citizens from financial and other risks. People cannot be provided by equal
and sufficient health services because of health insurance non-involvement,
breach of citizenship identification paper and no registration of citizenship. The
main reason of health insurance non-involvement depends on economic disad-
vantage and lack of information.
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OBJECTIVES: The implementation of the New Rural Cooperative Medical Scheme
(NRCMS) has been spreading fast since a county pilot trial began in September 2003.
The purpose of this survey was to guide policy makers of Huxian county and ulti-
mately improve the current national NRCMS policy. METHODS: Cross-sectional
survey of the attitudes of farmers towards the NRCMS conducted in 2005. A total of
1978 farmers living in 50 villages in Huxian Shaanxi Province were surveyed using
a door-to-door questionnaire. The survey asked farmers questions regarding their
awareness of the NRCMS and their opinions of the scheme, including methods of
reimbursement and raising funds and concerns regarding the scheme’s
sustainability.RESULTS:Most farmers hold a positive attitude towards theNRCMS.
There are issues, however, in regard to the farmers’ trust in the scheme and pre-
ferred payment methods. Farmers place more trust in village doctors rather than
village cadres for fund collection.More than two thirds of farmers visit county-level
hospitals directly when they require inpatient treatment. Not all hospitals and
doctors fully comply with the NRCMS rules, and supplier-induced demand is still
widespread. More than half the farmers stated that they worry that the NRCMS is
unable to be sustained. Importantly the survey showed a high enrolment rate of
92% (95% CI, 91; 93) in a voluntary insurance scheme. CONCLUSIONS: Despite a
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